title: [Gynaecologists' attitudes and practices towards HPV vaccination: a quantitative-qualitative study in Rhône-Alpes].
abstract: OBJECTIVE
  Acceptance of the human papilloma virus (HPV) vaccine by targeted population will mainly depend on its acceptability among gynaecologists. We examined the perceptions, attitudes and practices of gynaecologists in relation to HPV vaccination 1 year after licensing.
  
  
  METHODS
  From November 2007 to April 2008, a cross-sectional survey was carried among a representative 10% sample of gynaecologists in the French Rhône-Alpes region. Both quantitative (self-administered questionnaire) and qualitative (interview) approaches were used.
  
  
  RESULTS
  Among the 52 respondents, 90.4% of gynaecologists reported a favourable opinion about HPV vaccination, 5.8% were uncertain and 1.9% was opposed (one did not answer). The main justification for a favourable opinion related to the public health effects of the HPV vaccination (cited by 31.9% of those favouring vaccination). The main justification for an uncertain or opposed opinion was the too recent introduction of the vaccine (cited by 100%). During the month preceding the survey, 40.4% had provided HPV vaccination, mainly in 15-23 years old girls (38.5%). The major difficulties in providing HPV vaccination were questions asked by patients (cited by 44.2% of the respondents) and the targeted age of 14 years (13.5%). A total of 87.5% of respondents reported to have discussed with 14-year-old vaccinated girls of Pap-smear and 12.5% of STI prevention.
  
  
  CONCLUSIONS
  One year after HPV vaccine licensing, gynaecologists of Rhône-Alpes region had a favourable opinion about it, despite some difficulties. Little information about STI prevention to vaccinated girls was reported opposite to information about Pap-smear.
authors.affiliation: Département de santé publique, centre Léon-Bérard, 28, rue Laënnec, 69008 Lyon, France. magnin@lyon.fnclcc.fr
authors.forename: D
authors.initials: D
authors.lastname: Lutringer-Magnin
authors.forename: J
authors.initials: J
authors.lastname: Kalecinski
authors.forename: G
authors.initials: G
authors.lastname: Barone
authors.forename: H
authors.initials: H
authors.lastname: Borne
authors.forename: V
authors.initials: V
authors.lastname: Regnier
authors.forename: P
authors.initials: P
authors.lastname: Vanhems
authors.forename: F
authors.initials: F
authors.lastname: Chauvin
authors.forename: C
authors.initials: C
authors.lastname: Lasset
mesh_terms: D000293:Adolescent; D001291:Attitude of Health Personnel; D003430:Cross-Sectional Studies; D005260:Female; D005602:France; D006176:Gynecology; D006801:Humans; D008297:Male; D008875:Middle Aged; D030361:Papillomavirus Infections / Q000517:prevention & control; D053918:Papillomavirus Vaccines; D010818:Practice Patterns, Physicians'; D055815:Young Adult
chemical_list: D053918:Papillomavirus Vaccines